FMP

FMP

Enter

LNTH - Lantheus Holdings, I...

photo-url-https://images.financialmodelingprep.com/symbol/LNTH.png

Lantheus Holdings, Inc.

LNTH

NASDAQ

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 to detect cardiovascular disease; and Gallium-67 to detect various infections and cancerous tumors. The company also offers AZEDRA, a radiotherapeutic to treat adult and pediatric patients; Automated Bone Scan Index that calculates the disease burden of prostate cancer by quantifying the hotspots on bone scans; and Cobalt (Co 57), a non-pharmaceutical radiochemical; RELISTOR for opioid-induced constipation; and PYLARIFY for visualization of lymph nodes, bone, and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer. It also develops flurpiridaz F 18 to assess blood flow to the heart; 1095, a PSMA-targeted iodine-131 labeled small molecule; LMI 1195 for neuroblastoma tumors in pediatric and adults; PYLARIFY AI, an AI-based medical device software to perform standardized quantitative assessment of PSMA PET/CT images in prostate cancer; and leronlimab, an investigational humanized monoclonal antibody. The company serves radio pharmacies, distributors, integrated delivery networks, hospitals, clinics, and group practices. It has strategic partnerships with NanoMab Technology Limited; Bausch Health Companies, Inc.; GE Healthcare Limited; Curium; Bayer AG; CytoDyn Inc.; ROTOP; FUJIFILM; Regeneron Pharmaceuticals, Inc.; and POINT Biopharma US Inc. The company was founded in 1956 and is headquartered in North Billerica, Massachusetts.

91.47 USD

-0.11 (-0.12%)

LNTH Financial Statements

Year

2023

2022

2021

2020

Total Revenue

1.3B

935.06M

425.21M

339.41M

Cost of Revenue

586.89M

353.36M

237.51M

200.65M

Gross Profit

709.54M

581.7M

187.69M

138.76M

Operating Expenses

344.9M

545.51M

263.78M

142.96M

Research and Development

77.71M

311.68M

44.97M

32.79M

Selling, General & Administrative Expenses

267.19M

233.83M

218.82M

110.17M

Selling & Marketing Expenses

141.74M

100.24M

68.42M

40.9M

General & Administrative Expenses

125.46M

133.58M

150.4M

69.27M

Other Expenses

0

-1.7M

-7.35M

2.2M

Operating Income

364.64M

-13.44M

-76.09M

-4.2M

Total Other Income/Expenses Net

46.3M

-9.48M

-14.21M

-7.28M

Income Before Tax

410.94M

26.72M

-75.04M

-11.48M

Income Tax

84.28M

-1.35M

-3.76M

1.99M

Net Income

326.66M

28.07M

-71.28M

-13.47M

Basic EPS

4.79

0.41

-1.06

-0.25

EPS Diluted

4.65

0.4

-1.06

-0.25

Basic Average Shares

68.27M

68.49M

67.49M

54.13M

Diluted Average Shares

70.24M

70.67M

67.49M

54.13M

EBITDA

491M

81.83M

-25M

22.69M

Retained Earning Schedule

Year

2023

2022

2021

2020

Retained Earnings (Previous Year)

-193.16M

-221.22M

-149.95M

-136.47M

Net Income

326.66M

28.07M

-71.28M

-13.47M

Stock Repurchases

0

-75M

0

0

Dividend Paid

0

0

0

0

Retained Earnings

133.5M

-193.16M

-221.22M

-149.95M

Other Distributions

326.66M

-46.93M

-71.28M

-13.47M

PPE Schedule

Year

2023

2022

2021

2020

Gross PPE

192.02M

122.17M

116.77M

120.17M

Annual Depreciation

60.04M

47.93M

42.29M

24.69M

Capital Expenditure

-46.55M

-18.35M

-12.14M

-12.47M

Net PPE

178.53M

92.58M

86.62M

107.96M

Intangible and Goodwill Schedule

Year

2023

2022

2021

2020

Acquisitions and Adjustments

0

0

2.56M

42.92M

Goodwill (Previous Year)

61.19M

61.19M

58.63M

15.71M

Goodwill

61.19M

61.19M

61.19M

58.63M

All figures are in USD.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep